Literature DB >> 9199879

IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field.

S Hisano1, K Sakamoto, T Ishiko, H Kamohara, M Ogawa.   

Abstract

To investigate alterations in post-operative levels of IL-6 and soluble IL-6 receptor (sIL-6R), we examined their levels in serum and samples of drainage fluids from 26 patients who underwent thoracoabdominal surgery. Serum IL-6 levels reached the maximum within the first post-operative day and decreased thereafter. The IL-6 levels in the drainage fluid were much higher than in the serum (458 +/- 101-fold; mean +/- SEM) in the early post-operative phase. A large quantity of sIL-6R levels was present in blood samples. The time course of serum sIL-6R levels in 26 patients showed no significant change. sIL-6R concentrations in the drainage fluid were significantly lower than in serum (4.5 +/- 1.1-fold; mean +/- SEM) in the early post-operative phase. We propose that IL-6 is produced in the operative field and enters the peripheral blood stream to induce elevation of serum IL-6. On the other hand, sIL-6R levels in the operative field are lower than in the serum, and the serum sIL-6R levels are not influenced by surgical trauma. These data suggest that sIL-6R is being constantly produced in areas other than the operative field, while sIL-6R level is reduced by consumption in the operative field. Mechanisms to cope with surgical stress, involving sIL-6R together with its ligand IL-6 may thus exist.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199879     DOI: 10.1006/cyto.1996.0187

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Cytokine Response in the Pleural Fluid and Blood in Minimally Invasive and Open Esophagectomy.

Authors:  T Delko; D I Watson; B Beck-Schimmer; A Immanuel; D J Hussey; U Zingg
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  The influence of percutaneous nephrolithotomy on human systemic stress response, SIRS and renal function.

Authors:  Pengfei Shen; Wuran Wei; Xiaochun Yang; Hao Zeng; Xiong Li; Jie Yang; Jia Wang; Jiaoti Huang
Journal:  Urol Res       Date:  2010-03-04

3.  Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.

Authors:  H Eguchi; K Umeshita; M Sakon; H Nagano; Y Ito; S I Kishimoto; K Dono; S Nakamori; T Takeda; M Gotoh; K Wakasa; N Matsuura; M Monden
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

4.  Practical understanding of hemostasis and approach to the bleeding patient in the OR.

Authors:  Albert Pierce; Jean-Francois Pittet
Journal:  Adv Anesth       Date:  2014

5.  Cytokine & chemokine response in the lungs, pleural fluid and serum in thoracic surgery using one-lung ventilation.

Authors:  Andreas Breunig; Franco Gambazzi; Beatrice Beck-Schimmer; Michael Tamm; Didier Lardinois; Daniel Oertli; Urs Zingg
Journal:  J Inflamm (Lond)       Date:  2011-11-11       Impact factor: 4.981

6.  Host-related Risk Factors for Adherent Perinephric Fat in Healthy Individuals Undergoing Laparoscopic Living-donor Nephrectomy.

Authors:  Shintaro Narita; Teruaki Kumazawa; Norihiko Tsuchiya; Huang Mingguo; Mitsuru Saito; Takamitsu Inoue; Hiroshi Tsuruta; Kazuyuki Numakura; Atsushi Maeno; Hiroshi Nanjo; Shigeru Satoh; Tomonori Habuchi
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2017-08       Impact factor: 1.719

7.  Proinflammatory markers in prediction of posttraumatic psychological symptoms: a prospective cohort study.

Authors:  Alasdair George Sutherland; Gary A Cameron; David A Alexander; James D Hutchison
Journal:  Mediators Inflamm       Date:  2008-12-22       Impact factor: 4.711

8.  Relationship between cytokine gene polymorphisms and risk of postoperative pneumonia with esophageal cancer.

Authors:  Kazuhiko Sakamoto; Masaaki Oka; Shigehumi Yoshino; Shoichi Hazama; Shigeru Takeda; Kiyoshi Yoshimura; Naoko Okayama; Yuji Hinoda
Journal:  J Gastrointest Surg       Date:  2014-05-08       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.